Levofloxacina Rafarm

Levofloxacin, the active ingredient in Levofloxacina Rafarm, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial infections of the eye such as conjunctivitis and keratitis in patients of all ages. GNH USA supplies Levofloxacina Rafarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacina Rafarm is a fluoroquinolone antibiotic used to manage bacterial infections of the eye. - Bacterial conjunctivitis: reduces bacterial load and resolves infection of the conjunctiva. - Bacterial keratitis: eradicates corneal pathogens and promotes healing of the corneal epithelium. - Other susceptible ocular infections: effective against Gram‑positive and Gram‑negative organisms causing eye infections.

Levofloxacina Rafarm may cause ocular and systemic reactions.

Common Side Effects: - Burning or stinging sensation upon instillation. - Transient eye redness. - Blurred vision lasting a few minutes. - Itching or foreign‑body sensation. - Mild tearing. - Temporary eyelid swelling.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema, anaphylaxis). - Corneal ulceration or perforation. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Vision loss. - Persistent intraocular inflammation. - Tendon rupture (systemic exposure).

Before using Levofloxacina Rafarm, consider the following precautions. - Hypersensitivity: discontinue immediately if signs of severe allergic reaction appear. - Indication specificity: use only for confirmed bacterial ocular infections; avoid viral or fungal eye conditions. - Fluoroquinolone allergy: avoid in patients with known hypersensitivity to levofloxacin or other fluoroquinolones. - Corneal integrity: exercise caution in eyes with epithelial defects or recent surgery. - Pregnancy and lactation: safety not established; prescribe only if potential benefit outweighs risk. - Store at below 25°C: keep in original container, protect from moisture and light.

Levofloxacina Rafarm can interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Concurrent use of systemic fluoroquinolones: may increase risk of additive toxicity. - Cation‑containing eye drops (e.g., aluminum‑based antacids): can reduce ocular absorption.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask signs of infection or increase risk of corneal thinning. - Non‑steroidal anti‑inflammatory eye drops: monitor for delayed wound healing. - Antidiabetic medications: systemic absorption may affect glucose control; observe blood sugar levels.